McKesson is reshuffling its C-suite in a big way, as longtime finance chief Britt Vitalone prepares to retire this spring and the Irving-based healthcare giant lines up Sysco CFO Kenny Cheung as his successor for May 29. Vitalone is not exactly riding off into the sunset, though; he will stay on as an advisor to help guide the planned separation of McKesson's Medical‑Surgical Solutions business.
According to McKesson, Cheung will come aboard as executive vice president and chief financial officer effective May 29. CEO Brian Tyler called Vitalone an exceptional partner and leader in the company’s announcement, crediting his two-decade run with helping to reshape McKesson’s portfolio.
Transition timeline and pay package
The fine print is laid out in the company’s Form 8‑K filed with the SEC, which maps out exactly how the handoff will work. Vitalone’s last official day as CFO is scheduled for May 28, 2026. He will remain a McKesson employee through July 1, then shift into a paid advisory role starting July 2 at $50,000 per month.
The same filing spells out Cheung’s compensation to lure him from the food-distribution world to healthcare. His hiring package includes a $3.5 million sign‑on bonus, $6 million in sign‑on restricted stock units, a $1.05 million base salary and additional performance awards. Full details are available in the SEC filing.
Who is Kenny Cheung
Cheung comes to McKesson from Sysco, where he has served as executive vice president and chief financial officer since 2023. Before that, he was CFO at Hertz and held senior finance posts at Nielsen and General Electric, giving him a résumé built on large, complex companies that have seen their share of restructuring and balance-sheet surgery.
Sysco said Cheung will remain there through April 17 to help with a smooth transition, while McKesson has highlighted his experience in handling complex restructuring and capital allocation. GlobeNewswire outlines his background in more detail.
Local stakes and the planned split
For North Texas, this is not just an inside-baseball corporate move. McKesson is one of the Dallas area’s heavyweight employers, having moved its headquarters from San Francisco to Irving. The Dallas Morning News has previously noted the company’s relocation and its prominence in the region’s corporate rankings.
Vitalone’s post‑CFO advisory role is tied directly to one of McKesson’s biggest strategic projects: the planned separation of its Medical‑Surgical Solutions business. A statement from McKesson frames the CFO transition around that ongoing portfolio evolution, signaling that continuity on the finance side is a priority while the company works through the split.
Market reaction and what to watch
Wall Street did not shrug this off. MarketBeat showed McKesson shares down roughly 6% in the trading session after the announcement, suggesting investors are weighing both the leadership change and the timing of the Medical‑Surgical separation.
Analysts, for their part, are watching how Cheung may shape capital allocation, divestiture timing and the overall strategy once he settles into the role. Leerink Partners kept its Outperform rating on McKesson following the news, according to StreetInsider.
For investors and Dallas‑area stakeholders alike, May 29 is the date to circle for Cheung’s official start. Vitalone’s extended advisory stint suggests McKesson wants a steady hand on the financial wheel while it navigates the Medical‑Surgical separation. This story will be updated as additional filings and company disclosures roll in.
